Fundz

Osteal Therapeutics Closes An Oversubscribed $30 Million Series B Financing To Advance Platform Therapy For Treatment Of Musculoskeletal Infection

PRIVATEMar 08, 2022

Amount Raised

$30 Million

Round Type

Series B

DallasOtherHealthcareHealth Care

Description

Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing a new category of combination therapies for musculoskeletal infections, announced today the completion of an oversubscribed $30 million Series B equity financing. The proceeds will enable Osteal to continue development of its integrated technologies, advance the clinical development of its lead candidate, VT-X7 for treatment of periprosthetic joint infection and fund new research programs.

Quick answer

Osteal Therapeutics raised $30 Million in a Series B round, dated March 8, 2022. Osteal Therapeutics is based in Dallas, Texas, United States.

How much did Osteal Therapeutics raise?
Osteal Therapeutics raised $30 Million in a Series B round on March 8, 2022.
What does Osteal Therapeutics do?
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Where is Osteal Therapeutics based and how big is it?
Osteal Therapeutics is based in Dallas, Texas, United States. Fundz records about 49 employees.
Who are the decision-makers at Osteal Therapeutics?
Fundz holds 1 contact at Osteal Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Osteal Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Imagen Dental Partners raised $639K on April 22, 2022.
  • CytoDyn raised $1.9M (Seed) on April 22, 2022.
  • Accure Acne raised $3.5M (Seed) on April 19, 2022.
  • Optimize Systems raised $2M (Seed) on April 19, 2022.
  • Lungpacer Medical raised $20M on April 19, 2022.
  • Click Therapeutics raised $15M (Debt Financing) on April 15, 2022.

Who to call at Osteal Therapeutics, and when

A new round usually means Osteal Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Osteal Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Osteal Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Osteal Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Osteal Therapeutics

Location

4835 LYNDON B. JOHNSON FWY STE 635

Dallas, Texas, United States

About

Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Osteal Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Osteal Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Osteal Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Osteal Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.